Inlyta side effects - from FDA reports


Summary

In this review, we analyze Inlyta side effects by the time on the drug, gender and age of the people who have side effects while taking Inlyta. The review is based on 3,993 who side effects while taking the drug from FDA, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


Inlyta

Inlyta has active ingredients of axitinib. (latest outcomes from Inlyta 4,378 users)

On Mar, 25, 2017

3,993 people who take Inlyta are studied.


Number of reports submitted per year:

Inlyta side effects.

Most common side effects over time *:

< 1 month:
  • death
  • renal cell carcinoma
  • stomatitis
  • vomiting
  • weight decreased
  • hypertension
  • posterior reversible encephalopathy syndrome
  • renal cancer
  • metastatic renal cell carcinoma
  • renal impairment
1 - 6 months:
  • death
  • renal cancer
  • weight decreased
  • renal cell carcinoma
  • stomatitis
  • metastatic renal cell carcinoma
  • hypertension
  • neoplasm malignant
  • diarrhoea
  • interstitial lung disease
6 - 12 months:
  • death
  • renal cancer
  • renal cell carcinoma
  • metastatic renal cell carcinoma
  • vomiting
  • weight decreased
  • osteonecrosis of jaw
  • drug ineffective
  • seizure
  • diarrhoea
1 - 2 years:
  • renal cell carcinoma
  • metastatic renal cell carcinoma
  • renal cancer
  • stomatitis
  • death
  • drug ineffective
  • nephrotic syndrome
  • urinary tract infection
  • acute coronary syndrome
  • aphonia
2 - 5 years:
  • hypertension
  • ischaemic stroke
  • viral infection
  • interstitial lung disease
  • neoplasm malignant
  • renal cell carcinoma
  • white blood cell count decreased
  • disease progression
  • drug ineffective
  • drug resistance
5 - 10 years:
  • neoplasm malignant
10+ years:
  • osteonecrosis of jaw
not specified:
  • death
  • renal cancer
  • weight decreased
  • diarrhoea
  • neoplasm malignant
  • renal cell carcinoma
  • vomiting
  • nausea
  • fatigue
  • hypertension

Most common side effects by gender *:

female:
  • death
  • renal cancer
  • vomiting
  • weight decreased
  • diarrhoea
  • renal cell carcinoma
  • nausea
  • stomatitis
  • hypertension
  • fatigue
male:
  • death
  • renal cancer
  • weight decreased
  • renal cell carcinoma
  • diarrhoea
  • neoplasm malignant
  • vomiting
  • metastatic renal cell carcinoma
  • nausea
  • hypertension

Most common side effects by age *:

2-9:
  • pneumothorax
  • respiratory failure
10-19:
  • nausea
  • renal cancer
  • white blood cell count increased
20-29:
  • death
  • diarrhoea
  • leukoencephalopathy
  • pain
  • pneumonia
  • pyrexia
  • renal cancer
  • renal cell carcinoma
  • weight decreased
30-39:
  • death
  • renal cancer
  • vomiting
  • blood triglycerides increased
  • glycosuria
  • metastatic renal cell carcinoma
  • myalgia
  • nausea
  • palmar-plantar erythrodysaesthesia syndrome
  • pneumonia
40-49:
  • death
  • renal cancer
  • renal cell carcinoma
  • vomiting
  • weight decreased
  • metastatic renal cell carcinoma
  • nausea
  • diarrhoea
  • posterior reversible encephalopathy syndrome
  • pulmonary oedema
50-59:
  • death
  • renal cancer
  • renal cell carcinoma
  • weight decreased
  • vomiting
  • diarrhoea
  • nausea
  • neoplasm malignant
  • metastatic renal cell carcinoma
  • stomatitis
60+:
  • death
  • renal cancer
  • weight decreased
  • renal cell carcinoma
  • diarrhoea
  • vomiting
  • metastatic renal cell carcinoma
  • stomatitis
  • nausea
  • hypertension

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Are you taking Inlyta?

Related studies

All Inlyta side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Inlyta (axitinib) is often used to treat renal cell carcinoma. Find out below the conditions the drugs are used for and how effective they are.

You may be interested in these reviews

More reviews for: Inlyta